Psychiatric comorbidity and pharmacological treatment patterns among patients presenting with insomnia - An assessment of office-based encounters in the USA in 1995 and 1996
Tl. Skaer et al., Psychiatric comorbidity and pharmacological treatment patterns among patients presenting with insomnia - An assessment of office-based encounters in the USA in 1995 and 1996, CLIN DRUG I, 18(2), 1999, pp. 161-167
Background: Epidemiological studies reveal that approximately one-third of
the US adult population experiences insomnia, and that nearly 10% report it
to be a serious or chronic problem. Little is known as to the extent of ph
ysician diagnosis of the underlying illness, or the prescribing of pharmaco
therapy for this complaint.
Objectives: To discern among US ambulatory patients presenting with insomni
a as either the primary complaint, or as one of several reasons for request
ing a physician-patient office-based encounter (visit), the percentage of s
aid encounters wherein: (i) a diagnosis of insomnia was recorded [Internati
onal CIassification of Diseases, 9th Revision, Clinical Modification (ICD-9
-CM) codes 307.41, 307.42, 307.49, 780.50, 780.52, 780.55, 780.56, 780.59];
(ii) a diagnosis of a concomitant mental disorder (non-sleep-related) was
recorded (ICD-9-CM codes 290-307.39, 307.5-319); (iii) a diagnosis of a dep
ressive illness was recorded (ICD-9-CM codes 296.2-296.36, 300.4, 311); (iv
) a regimen of a hypnosedative was continued or prescribed [National Drug C
ode (NDC) 0626]; (v) a regimen of antidepressant pharmacotherapy was contin
ued or prescribed (NDC 0630); and (vi) a diagnosis of depression was record
ed and a regimen of antidepressant pharmacotherapy was continued or prescri
bed.
Methods: Data from the National Ambulatory Medical Care Survey for the year
s 1995 and 1996, for adults aged 18 years or older, were utilised for this
analysis.
Results: In the time-frame 1995 to 1996, an annualised mean of 3 027 312 pa
tients presented with a complaint of insomnia as one of three reasons recor
ded for requesting an office-based visit. Insomnia was the primary reason f
or an office-based visit in 35.1% (1 061 396) of these patients. The majori
ty of these patients were female (55.6%), White (66.2%), and had a mean age
of 53.2 years (+/- 16.8 years). Compared with patients presenting with ins
omnia as one of three reasons for the visit, a higher proportion of patient
s presenting with insomnia as the primary reason for the visit were diagnos
ed with insomnia (18.8%), diagnosed with a non-sleep-related mental disorde
r (57.4%), diagnosed with depression (31.7%), prescribed or continuing a re
gimen of hypnosedative pharmacotherapy (16.1%), prescribed or continuing a
regimen of antidepressant pharmacotherapy (48.3%), or diagnosed with depres
sion and prescribed or continuing a regimen of antidepressant pharmacothera
py (27.8%). Only 15.8% of the reporting physicians were psychiatric special
ists.
Conclusions: Our findings indicate that fewer than 5% of US adults with ins
omnia reported visiting a physician specifically for this problem. The resu
lts suggest that insomnia is multifactorial in origin, with the majority of
patients having been diagnosed with a non-sleep-related mental disorder, p
rimarily depression.